Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2022-06-02 Sale |
2022-06-03 4:13 pm |
GENOCEA BIOSCIENCES INC. | GNCA | Duvall Diantha CHIEF FINANCIAL OFFICER |
1,355 | $0.06 | $81 | 75,388 (Direct) |
View |
2022-05-26 Sale |
2022-05-26 4:11 pm |
GENOCEA BIOSCIENCES INC. | GNCA | Duvall Diantha CHIEF FINANCIAL OFFICER |
24,407 | $0.0765 | $1,867 | 76,743 (Direct) |
View |
2022-04-04 Sale |
2022-04-05 08:17 am |
GENOCEA BIOSCIENCES INC. | GNCA | Duvall Diantha CHIEF FINANCIAL OFFICER |
963 | $1.25 | $1,204 | 91,775 (Direct) |
View |
2022-03-16 Sale |
2022-03-17 4:11 pm |
GENOCEA BIOSCIENCES INC. | GNCA | Duvall Diantha CHIEF FINANCIAL OFFICER |
2,873 | $1.1 | $3,160 | 205,238 (Direct) |
View |
2021-04-02 Sale |
2022-03-16 5:31 pm |
GENOCEA BIOSCIENCES INC. | GNCA | Duvall Diantha CHIEF FINANCIAL OFFICER |
1,436 | $2.5392 | $3,646 | 62,486 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2025-01-28 Option Award |
2025-01-30 4:11 pm |
N/A 2035-01-27 |
CURIS INC | CRIS | Duvall Diantha CFO |
15,000 | $3.13 | 15,000 (Direct) |
View |
2024-05-21 Option Award |
2024-05-23 4:12 pm |
N/A 2034-01-18 |
CURIS INC | CRIS | Duvall Diantha CFO |
39,000 | $11.62 | 39,000 (Direct) |
View |
2023-01-20 Option Award |
2023-01-24 4:10 pm |
N/A 2033-01-19 |
CURIS INC | CRIS | Duvall Diantha CFO |
500,000 | $0 | 500,000 (Direct) |
View |
Ownership |
2022-08-10 4:00 pm |
N/A 2032-07-25 |
CURIS INC | CRIS | Duvall Diantha CFO |
0 | $0 | 540,000 (Direct) |
View |
2022-03-15 Option Award |
2022-03-17 4:11 pm |
N/A 2032-03-15 |
GENOCEA BIOSCIENCES INC. | GNCA | Duvall Diantha CHIEF FINANCIAL OFFICER |
150,000 | $0 | 205,238 (Direct) |
View |
2021-03-15 Option Award |
2021-03-17 1:59 pm |
N/A 2031-03-15 |
GENOCEA BIOSCIENCES INC. | GNCA | Duvall Diantha CHIEF FINANCIAL OFFICER |
250,000 | $0 | 250,000 (Direct) |
View |
2020-06-01 Option Award |
2020-06-02 4:19 pm |
N/A 2030-06-01 |
GENOCEA BIOSCIENCES INC. | GNCA | Duvall Diantha CHIEF FINANCIAL OFFICER |
31,561 | $0 | 31,561 (Direct) |
View |